3D Biotek
Private Company
Total funding raised: $338K
Overview
Founded in 2004 (incorporated 2007), 3D Biotek is a private, revenue-generating company focused on advanced 3D cell culture technologies. Its product portfolio includes the 3D Insert scaffolds and the 3D Cell Expansion System (3D-CES), targeting the research tools and contract services markets. The company's value proposition centers on providing more physiologically relevant in vitro models to improve drug screening efficiency and enable large-scale cell expansion for therapeutic applications.
Technology Platform
Precision 3D Micro-Fabrication Technology and Advanced Bio-Manufacturing Technology for creating porous scaffolds and bioreactor systems for 3D cell culture.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
3D Biotek competes in the 3D cell culture market against major players like Corning, Thermo Fisher Scientific, and Merck (MilliporeSigma), as well as specialized bioreactor companies. Its differentiation lies in its dedicated focus on 3D microfabrication, integrated expansion systems, and custom manufacturing services for specialized scaffolds.